(Q35070425)

6 August 2017

1 reference

title

Optimal therapy and management of endometrial cancer (English)

1 reference

6 August 2017

1

Yukio Sonoda

1 reference

6 August 2017

1 February 2003

1 reference

Expert Review of Anticancer Therapy

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

1

1 reference

6 August 2017

37-47

1 reference

6 August 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

Tamoxifen-induced uterine abnormalities: the role of imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

Conservative management of stage I endometrial carcinoma after surgical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.1.37

21 January 2018

Identifiers

DOI

10.1586/14737140.3.1.37

1 reference

6 August 2017

1 reference

PubMed ID

12597348